Covid-19: Now Chile limits use of AstraZeneca after clot case

accreditation
0:00
play article
Subscribers can listen to this article
Another country has limited the use of AstraZeneca vaccines.
Another country has limited the use of AstraZeneca vaccines.
Getty Images

Chile on Thursday became the latest country to limit use of the AstraZeneca coronavirus vaccine, linked to rare blood clots, when a 31-year-old man developed thrombosis after being immunized.

Pending further investigation and as a "preventative and proactive measure," the shot will in future be administered only to people 45 and over, the health ministry of the South American country said.

It did not give details on the condition of the man who fell ill after receiving a first shot of the vaccine.

Chile has already administered 326 560 doses of AstraZeneca, mainly but not exclusively to people over the age of 55 to limit the risk of blood clots reported in other countries.

Besides AstraZeneca, of which it has ordered six million doses, Chile also uses the Pfizer/BioNTech shot and China's Coronavac.

To date, the country has given at least one vaccine dose to 10.8 million people out of a 15.2 million target population - one of the highest rates in the world.


We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
15.57
+1.0%
Rand - Pound
19.66
-0.0%
Rand - Euro
16.71
-0.0%
Rand - Aus dollar
11.15
-0.0%
Rand - Yen
0.12
-0.0%
Gold
1,853.66
0.0%
Silver
22.12
0.0%
Palladium
2,076.50
0.0%
Platinum
956.50
0.0%
Brent Crude
119.43
+1.7%
Top 40
63,883
+1.4%
70,486
+1.4%
Resource 10
76,948
+0.6%
Industrial 25
76,115
+1.3%
Financial 15
16,257
+2.5%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE